In addition, it has also been shown that tumor-derived EVs may enhance the radiosensitivity of NPC by delivering miR-142-5p to radiotherapy-resistant NPC cells to inhibit the HGF/c-Met and EGF/EGFR pathways (Zhu et al., 2022). The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.